Implants used during cranial reconstruction procedures after cranial abnormalities are known as cranial implants. Trauma, infection, or malignancy is the most frequent causes of cranial anomalies. Specific face characteristics are enhanced through facial implantation. Cranial implants are used in cranial reconstruction surgeries after cranial anomalies to help protect intracranial structures, restore skull shape, normalize cerebral hemodynamics, and more. Trauma, infection, and other reasons frequently result in cranial abnormalities.
The market worth of cranial implants in 2021 was USD 1.08 billion, and it will be worth USD 1.94 billion by 2030, growing at a 6.63% CAGR during the forecast period.
The market for cranial implants is anticipated to expand over the projected period due to the increased frequency of neurological illnesses and traffic accidents. The treatment of neurological disorders will be made simpler by a cranial implant, allowing doctors to view the inside of the brain without repeatedly drilling a new hole in the skull.
The market for cranial implants is expanding due to an aging population, an increase in trauma occurrences, and greater research and development initiatives. The market for cranial implants has grown due to improved medical procedures made possible by the public’s increased awareness of health issues.
The leading competitors in the cranial implants market are gaining growth potential due to the rising number of technological developments driving the demand for efficient and effective cranial implantation.
Implant failure rates significantly rise since most cranial implantation surgeries are conventional (i.e., the clinician completes the entire procedure by hand). As a result, many patients choose different solutions, which slow market expansion.
Recently found, newer applications can drive the global market trends for cranial implants. Brain tumors, craniosynostosis, ischemic disorders (such as cerebral ischemia and ischemic stroke), anaplastology, maxillofacial surgery, prosthetics, and cerebral hemodynamics can all be treated with cranial implants by reshaping the skull and employing bone grafts. According to the CDC, nearly 87% of all recorded strokes are ischemic strokes, while the National Brain Tumor Society estimates that 700,000 Americans live with primary brain tumors.
On the basis of product, the market is segmented into non-customized and customized.
During the forecast period, the customized cranial implants sector will hold the largest market share of roughly 78%. Since each skull injury is distinct and necessitates a specific implant, the increase in market share can be related to surgeons’ rising demand for products. It is anticipated that the increased incidence of brain tumors brought on by genetic disorders and unbalanced lifestyles, together with an increase in wounds, injuries, and traffic accidents, will boost demand and impact segment growth.
By material, the market for cranial implants is segmented into metal, ceramic, and polymer.
The polymer material will have the greatest worldwide cranial implant market size throughout the projected period. Polymer like polyetheretherketone (PEEK) is the most frequently used material to make cranial implants. It is available in liquid or powder form, mixed to fit the contours of cranial abnormalities after surgery.
On the basis of end-user, the market is segmented into neurosurgical centers and hospitals.
The neurosurgery centers segment maintained the largest market position with a share of around 71% due to the specialized and tailored treatment of patients. Additionally, there is a rising need for neurosurgical institutes due to improved outcomes compared to hospitals. Additionally, neurosurgical centers ensure that patients receive individualized care, improving the patient experience.
The hospital segment is expanding at the fastest rate due to the availability of skilled neurosurgeons and rising disposable income among people. Multiple therapy sessions are required due to the rise in brain traumas, anomalies, and injuries, which will fuel the growth of this market segment. Additionally, expanding healthcare systems in developing countries and rising consumer acceptance of novel products will probably promote segment expansion.
North America considerably ruled the market with the largest share and will grow at a 5.5% CAGR. The market is expanding due to the prevalence of brain cancer and trauma, the adoption of technologically advanced technologies, and higher healthcare spending by local governments. The Canadian Cancer Society predicts that 3200 Canadians will be detected with spinal cord and brain cancer in 2022, with 1350 women and 1850 men receiving the diagnosis.
- KLS Martin Group
- Stryker Corporation
- Braun Melsungen AG
- DePuySynthes (a Johnson & Johnson subsidiary)
- ZIMMER BIOMET HOLDINGS INC
- evonos GmbH & Co. KG
- Medartis Holding AG
- Renishaw PLC
- Kelyiniam Global, Inc.
- Xilloc Medical BV.
- Anatomics Pty Ltd.
- EUROS SAS
The market worth of cranial implants in 2021 was USD 1.08 billion, and it will be worth USD 1.94 billion by 2030, growing at a 6.63% CAGR during the forecast period. The market expansion is driven by the rising occurrence of neurological disorders, traumas, wounds, and traffic accidents, as well as increased professional awareness.